Literature DB >> 17715111

MRI and biologic behavior of desmoid tumors in children.

M Beth McCarville1, Fredric A Hoffer, C Scott Adelman, Joseph D Khoury, Chenghong Li, Stephen X Skapek.   

Abstract

OBJECTIVE: The outcome of desmoid tumor in children cannot be reliably predicted on the basis of histologic findings. We sought to determine whether the postoperative presence of residual or recurrent tumor can be predicted on the basis of demographic variables and baseline MRI features of the tumor. We also aimed to determine how imaging features change during adjuvant treatment and how the imaging features relate to the histologic features.
MATERIALS AND METHODS: Two radiologists retrospectively reviewed images from 281 MRI examinations performed at baseline and during postoperative therapy for desmoid tumor. The examinations had been performed on 17 children treated between September 1991 and March 2003. Tumor volume; distinctness of margins; involvement of bone and neurovascular bundle; and T1-weighted, T2-weighted, and STIR signal intensity and contrast enhancement pattern were recorded. Baseline imaging and demographic features were correlated with the postoperative presence of residual or recurrent tumor. Imaging changes during follow-up were compared with treatment response and outcome. The imaging features of eight tumors were compared with percentage cellularity and collagen deposition in biopsy samples obtained within 30 days of imaging.
RESULTS: Baseline involvement of the neurovascular bundle approached significance as a predictor of the presence of residual or recurrent tumor (p = 0.08). Other baseline imaging and demographic features were not predictive (p > or = 0.4). Changes in imaging features were variable during follow-up. T2-weighted and STIR signal intensity may be correlated with percentage cellularity and collagen deposition.
CONCLUSION: MRI has limited value in prediction of the postoperative presence of residual or recurrent desmoid tumor in children. It is useful, however, for detecting disease and monitoring postoperative adjuvant therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17715111     DOI: 10.2214/AJR.07.2334

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

1.  Diagnostic imaging and CEUS findings in a rare case of Desmoid-type fibromatosis. A case report.

Authors:  Massimo Valentino; Mauro Liberatore; Fabrizio Maghella; Valeria De Soccio; Carlo De Felice; Daniela Messineo; Francesco Maria Drudi
Journal:  J Ultrasound       Date:  2018-03-21

Review 2.  Imaging spectrum of mesenteric masses.

Authors:  Radwan Diab; Mayur Virarkar; Mohammed Saleh; Sherif Elsheif; Sanaz Javadi; Priya Bhosale; Silvana Faria
Journal:  Abdom Radiol (NY)       Date:  2020-11

3.  Imaging of childhood inflammatory myofibroblastic tumor.

Authors:  Berna Oguz; Hatice Nursun Ozcan; Burak Omay; Burce Ozgen; Mithat Haliloglu
Journal:  Pediatr Radiol       Date:  2015-07-02

4.  MRI and CT of Low-Grade Fibromyxoid Sarcoma in Children: A Report From Children's Oncology Group Study ARST0332.

Authors:  Kiran Sargar; Simon C Kao; Sheri L Spunt; Douglas S Hawkins; David M Parham; Cheryl Coffin; M Beth McCarville
Journal:  AJR Am J Roentgenol       Date:  2015-08       Impact factor: 3.959

5.  CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping.

Authors:  Thomas Naert; Dieter Tulkens; Tom Van Nieuwenhuysen; Joanna Przybyl; Suzan Demuynck; Matt van de Rijn; Mushriq Al-Jazrawe; Benjamin A Alman; Paul J Coucke; Kim De Leeneer; Christian Vanhove; Savvas N Savvides; David Creytens; Kris Vleminckx
Journal:  Proc Natl Acad Sci U S A       Date:  2021-11-23       Impact factor: 12.779

6.  MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumours.

Authors:  Firouzeh Kamali; Wei-Lien Wang; B A Guadagnolo; Patricia S Fox; Valerae O Lewis; Alexander J Lazar; Anthony P Conley; Vinod Ravi; Mohammad Toliyat; Harshad S Ladha; Brian P Hobbs; Behrang Amini
Journal:  Br J Radiol       Date:  2015-11-18       Impact factor: 3.039

7.  Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors.

Authors:  Jennifer L Kujak; Patrick T Liu; Geoffrey B Johnson; Matthew R Callstrom
Journal:  Skeletal Radiol       Date:  2009-09-21       Impact factor: 2.199

8.  A Novel Method to Treat Progressive Desmoid Tumors Involving Neurovascular Bundles: A Retrospective Cohort Study.

Authors:  Jun-Qiang Yin; Yi-Wei Fu; Zhen-Hua Gao; Chang-Ye Zou; Xian-Biao Xie; Bo Wang; Zhi-Hai Zhong; Gang Huang; Jing-Nan Shen
Journal:  Neurosurgery       Date:  2021-05-13       Impact factor: 4.654

9.  The Clinical and Radiological Characteristics of Inflammatory Myofibroblastic Tumor Occurring at Unusual Sites.

Authors:  Xuewei Zeng; Huayi Huang; Jun Li; Jiayou Peng; Jiaxiong Zhang
Journal:  Biomed Res Int       Date:  2018-05-14       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.